Recent Acquisitions Boston Scientific has been actively acquiring companies like Intera Oncology, Cortex, and Cortexhc, indicating a growth strategy focused on expanding its product offerings. These acquisitions present sales opportunities to cross-sell new solutions to existing clients and penetrate new market segments.

Launch of AVVIGO The recent launch of AVVIGO, a multi-modality guidance system, showcases Boston Scientific's commitment to innovation. Sales development representatives can leverage this new product to attract tech-savvy healthcare facilities and differentiate themselves from competitors, potentially leading to increased sales.

Investment from GDS Wealth Management The investment of $490,000 by GDS Wealth Management demonstrates confidence in Boston Scientific's growth potential. Sales professionals can leverage this financial backing to build trust with potential clients and investors, potentially facilitating larger sales deals and partnerships.

Recognized as Best Low Volatility Stock Being recognized as one of the Best Low Volatility Stocks highlights Boston Scientific's stability and reliability as an investment. Sales development professionals can use this accolade to attract risk-averse investors and position the company as a safe choice for long-term partnerships and sales agreements.

Comparison with Similar Companies When assessing Boston Scientific's position relative to similar companies like GE Healthcare, Zimmer Biomet, and Medtronic, sales professionals can identify key differentiators to emphasize during sales pitches. Highlighting Boston Scientific's unique value propositions can help to capture market share from competitors and drive sales growth.